INCYTE CORPORATION Repayments of Convertible Debt
INCYTE CORPORATION (INCY) reported Repayments of Convertible Debt of $499.99 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-02-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2016-02-12
- INCYTE CORPORATION repayments of convertible debt for the quarter ending 2013-12-31 was $488.73M.
- INCYTE CORPORATION repayments of convertible debt for the quarter ending 2013-09-30 was $1.49M.
- INCYTE CORPORATION repayments of convertible debt for the quarter ending 2010-12-31 was $0.00.
- INCYTE CORPORATION repayments of convertible debt for the quarter ending 2010-09-30 was $0.00.
- INCYTE CORPORATION repayments of convertible debt for fiscal 2013 was $499.99M.
- INCYTE CORPORATION repayments of convertible debt for fiscal 2010 was $158.64M, a 28.95% decline from fiscal 2009.
- INCYTE CORPORATION repayments of convertible debt for fiscal 2009 was $223.29M.
| Period end | Repayments of Convertible Debt 1 month | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | $488.73M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $490.22M derived: sum of 2 quarters · filed 2016-02-12 | $499.99M 10-K · filed 2016-02-12 | ||
| 2013-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $11.26M 10-Q · filed 2013-10-31 | |||
| 2013-06-30 | $9.77M 10-Q · filed 2013-08-01 | ||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $0.00 derived: sum of 2 quarters · filed 2013-02-21 | $0.00 derived: sum of 3 quarters · filed 2013-02-21 | $158.64M 10-K · filed 2013-02-21 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $0.00 derived: sum of 2 quarters · filed 2011-10-27 | $158.64M 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $158.64M 10-Q · filed 2011-07-28 | |||
| 2010-03-31 | $158.64M 10-Q · filed 2011-05-03 | ||||
| 2010-02-28 | $158.60M 10-K · filed 2012-02-22 | ||||
| 2009-12-31 | $223.29M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |